Is Colgate-Palmolive (CL) Expensive As Investors Weigh Its Premium P/E And Fair Value Gap?
What Is Driving Interest In Colgate-Palmolive Stock Now
Recent commentary on Colgate-Palmolive (CL) has focused on its strong brand recognition, premium pricing, and free cash flow profile, with current valuation at 22.8x forward P/E putting investor attention on whether that pricing looks demanding.
At a share price of US$90.10, Colgate-Palmolive has delivered a 15.97% year to date share price return. Its 1-year total shareholder return of 10.19% and 3-year total shareholder return of 33.66% suggest steady compounding that aligns with growing interest in its premium P/E valuation and cash generation story.
Compare Colgate-Palmolive's premium P/E and cash generation with a hand picked group of quality stocks that have been screened for strong fundamentals using the 54 high quality undervalued stocks.
After a near 16% move in 2026 and a forward P/E of 22.8x, Colgate-Palmolive now poses a simple question: Do you accept the current premium, or wait and hope for a cheaper entry as conditions shift?
Most Popular Narrative: 4% Overvalued
On the most followed narrative, Colgate-Palmolive’s fair value of $86.48 sits slightly below the recent $90.10 share price, which keeps attention on how that small gap is justified.
The distortion runs through every derived metric. The dividend payout looks stretched at roughly 82% of GAAP EPS and is about 57% of Base Business EPS. The stock looks expensive at 35 times GAAP earnings and trades near 24 times normalised. The trailing twelve month margin carries the same contamination, because the fourth quarter of 2025 still sits inside the window.
Want to see what happens once that impairment is stripped out. The narrative leans on higher normalised margins, modest revenue growth and a specific profit multiple to reach its fair value.
According to rcb9, the narrative is built around a three part framework. First, it cleans up Colgate-Palmolive’s reported earnings by adjusting for the $794m non cash skin health impairment that pulled 2025 GAAP net income down to $2.13b and pushed the headline net margin to about 10%. Second, it anchors on a higher, normalised profit margin and a revenue growth profile that sits in the mid single digit range over several years. Third, it pairs that earnings path with a future P/E of 24x and discounts the cash flows back at 7% to arrive at the $86.48 fair value.
The quote above highlights one key message from that framework. If you adjust the margin but still plug in a P/E that was calculated on unadjusted GAAP earnings, you effectively give Colgate-Palmolive the benefit of the impairment reversal twice. That would inflate any fair value number and, according to the narrative, could overstate it by roughly 45% compared with running both margin and multiple on the same earnings basis.
On the numbers provided, the gap between Colgate-Palmolive’s share price and this fair value narrative is modest. The discount to fair value sits at about 4.2% in the narrative data, which places the stock close to the level implied by that 7% discount rate, mid single digit revenue growth and a 15% profit margin profile.
Result: Fair Value of $86.48 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Colgate-Palmolive still faces two clear pressure points. A slower than expected North America recovery or another skin health impairment could quickly challenge this 4% overvaluation gap.
Find out about the key risks to this Colgate-Palmolive narrative.
Another View On Colgate-Palmolive’s Valuation
While the most followed narrative sees Colgate-Palmolive as about 4% overvalued at $90.10, our DCF model paints a different picture. On that approach, the stock price sits roughly 29.7% below an estimated fair value of $128.20, which frames the current premium P/E in a very different light.
The gap between a slightly expensive earnings-based view and a materially undervalued DCF output leaves you with a practical question: Which set of assumptions on growth, margins and discount rate feels closer to how you see Colgate-Palmolive?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Colgate-Palmolive for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 54 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
The mixed signals around Colgate-Palmolive’s valuation, risks and rewards make this a moment to act quickly and test the numbers yourself. To weigh the full context of both concerns and potential upside, review the 3 key rewards and 3 important warning signs.
Looking For More Investment Ideas Beyond Colgate-Palmolive?
If Colgate-Palmolive has you rethinking valuation and quality, do not stop here. Use focused stock lists to pressure test your approach and uncover alternatives fast.
- Target stability first and see which companies show resilient finances through the 75 resilient stocks with low risk scores.
- Hunt for quality at a reasonable price by checking companies that screen as 54 high quality undervalued stocks.
- Spot potential compounders with strong fundamentals that the market may be overlooking through the 20 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com